Managers / Q1 2026
Noked Israel Ltd
CIK 0001767750 · 22 HAGEFEN ST, RAMAT HASHARON, L3, 4725422 · 972-73-780-3400
Summary
Noked Israel Ltd reported $677M in U.S.-listed holdings across 13 positions for Q1 2026.
The portfolio is heavily concentrated: TSM alone accounts for 45.4% of reported value.
Compared with Q4 2025, the fund opened 2 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ADR · 45.5% · $308M
- Common Stock · 36.5% · $247M
- ETP · 18.0% · $122M
- Other · 0.0% · $198,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SOXXISHARES TR | NEW | +349.1K | 349.1K | +$115M | $115M |
| XTLBXTL BIOPHARMACEUTICALS LTD | NEW | +49.7K | 49.7K | +$120,000 | $120,000 |
| AMZNAMAZON COM INC | ADDED | +89.3K | 119.1K | +$18M | $25M |
| NVDANVIDIA CORPORATION | SOLD OUT | −158.3K | 0 | −$30M | $0 |
| PANWPALO ALTO NETWORKS INC | SOLD OUT | −96.0K | 0 | −$18M | $0 |
| XTL BIOPHARMACEUTICALS LTD | SOLD OUT | −198.9K | 0 | −$115,000 | $0 |
| MSFTMICROSOFT CORP | TRIMMED | −149.3K | 45.1K | −$77M | $17M |
| GOOGALPHABET INC | ADDED | +130.8K | 317.2K | +$33M | $91M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | TSMTAIWAN SEMICONDUCTOR MFG LTDhistory → | SPONSORED ADS | 45.45% | $308M | 910.4K |
| 2 | SOXXISHARES TRhistory → | ISHARES SEMICDTR | 16.95% | $115M | 349.1K |
| 3 | GOOGALPHABET INChistory → | CAP STK CL C | 13.44% | $91M | 317.2K |
| 4 | NVMINOVA LTDhistory → | COM | 7.57% | $51M | 118.0K |
| 5 | GE AEROSPACE | COM NEW | 6.83% | $46M | 162.8K |
| 6 | AMZNAMAZON COM INChistory → | COM | 3.66% | $25M | 119.1K |
| 7 | MSFTMICROSOFT CORPhistory → | COM | 2.47% | $17M | 45.1K |
| 8 | METAMETA PLATFORMS INChistory → | CL A | 2.33% | $16M | 27.5K |
| 9 | QQQINVESCO QQQ TR | UNIT SER 1 | 0.59% | $4M | 6.9K |
| 10 | SPYSTATE STR SPDR S&P 500 ETF T | TR UNIT | 0.46% | $3M | 4.8K |
| 11 | ODYSODYSIGHT AI INC | COM NEW | 0.21% | $1M | 201.0K |
| 12 | G WILLI FOOD INTL LTD | ORD | 0.03% | $198,000 | 8.0K |
| 13 | XTLBXTL BIOPHARMACEUTICALS LTD | SPONSORED ADS | 0.02% | $120,000 | 49.7K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $677M | 13 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $624M | 14 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $639M | 14 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $542M | 12 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $436M | 15 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $508M | 16 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $458M | 18 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $362M | 15 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $372M | 22 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $379M | 31 | Feb 15, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2023 | $330M | 28 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $292M | 35 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $230M | 22 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $262M | 27 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $411M | 50 | Dec 27, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2022 | $435M | 48 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $329M | 42 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $407M | 45 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $425M | 46 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $401M | 35 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $307M | 33 | May 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $243M | 27 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $151M | 22 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $140M | 16 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $56M | 14 | May 27, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2019 | $89M | 58 | Feb 18, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $95M | 38 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $82M | 81 | Aug 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $96M | 72 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Noked Capital LTD028-19105
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.